At the 2019 Hairy Cell Leukemia Foundation Annual Conference new findings showed promise in the safety of vemurafenib to treat patients with hairy cell leukemia.
Agnieszka Janus, MD, PhD
Advertisement
Articles by Agnieszka Janus, MD, PhD
Advertisement
Latest Updated Articles
Expert Discusses the Safety of VemurafenibPublished: October 27th 2019 | Updated:
Advertisement
Advertisement
